Cayston 75 MG inhal solutionml
Ended Awarded
- Contract number
- SPE2DB26FH4TQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,679
Award facts
- Contract value 100% obligated
- $7,679.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,679.39 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Cayston 75 mg inhalation solution. This delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and will be performed at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs for military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB26FH4TQ?
SPE2DB26FH4TQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FH4TQ worth?
The government has obligated $7,679 on SPE2DB26FH4TQ.
Is contract SPE2DB26FH4TQ an order under another contract?
Yes. SPE2DB26FH4TQ is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB26FH4TQ competed?
The extent of competition for SPE2DB26FH4TQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award